Mirum Pharmaceuticals, Inc

(NASDAQ:MIRM)

Latest On Mirum Pharmaceuticals, Inc (MIRM):

Date/Time Type Description Signal Details
2023-05-07 08:03 ESTNewsMirum Pharmaceuticals, Inc. (MIRM) Q1 2023 Earnings Call TranscriptN/A
2023-05-05 03:10 ESTNewsMirum Pharmaceuticals Non-GAAP EPS of -$0.80 beats by $0.17, revenue of $31.6M beats by $0.81MN/A
2023-05-04 01:50 ESTNewsMirum Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-04-30 09:44 ESTNewsMirum Pharmaceuticals: Staying The CourseN/A
2023-04-13 08:06 ESTNewsMirum Pharmaceuticals prices notes worth $275MN/A
2023-04-12 19:36 ESTNewsMirum Pharmaceuticals reports preliminary unaudited financial results for Q1 2023N/A
2023-03-09 03:57 ESTNewsMirum Pharmaceuticals, Inc. (MIRM) Q4 2022 Earnings Call TranscriptN/A
2023-02-14 11:04 ESTNewsMirum files for expanded approval of Livmarli in USN/A
2023-02-01 18:54 ESTNewsMirum Pharmaceuticals: In The Spotlight Following Buyout Of Albireo PharmaN/A
2022-11-29 09:10 ESTNewsMirum drops plans to develop liver disease candidate in pregnancyN/A
2022-11-20 19:55 ESTNewsMirum: Potential For European Approval To Move It ForwardN/A
2022-11-10 02:53 ESTNewsMirum Pharmaceuticals, Inc. (MIRM) Q3 2022 Earnings Call TranscriptN/A
2022-11-09 08:41 ESTNewsMirum Pharmaceuticals GAAP EPS of -$1.02 beats by $0.05, revenue of $18.78M misses by $2.03MN/A
2022-10-25 00:08 ESTNewsMirum says liver disease therapy met main goal in late-stage studyN/A
2022-10-14 19:50 ESTNewsMirum's liver disease drug Livmarli gets EMA committee nod for approval in EUN/A
2022-08-17 21:12 ESTNewsMirum: Great Sales Start For Livmarli Paves The Way For Long-Term GrowthN/A
2022-08-10 20:11 ESTNewsMirum Pharmaceuticals stock falls prices $80.0M stock offeringN/A
2022-08-10 02:57 ESTNewsMirum Pharmaceuticals falls aftermarket on $80M stock offeringN/A
2022-08-08 04:34 ESTNewsMirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-05 05:13 ESTNewsMirum Pharmaceuticals GAAP EPS of -$0.84 beats by $0.31, revenue of $17.5M beats by $2.08MN/A
2022-08-03 23:16 ESTNewsMirum Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-05-27 23:11 ESTNewsMirum Pharmaceuticals: Post-Approval Execution Looks ExcellentN/A
2022-05-24 00:37 ESTNewsMirum acquires San Diego-based Satiogen in stock and cash combinationN/A
2022-05-08 01:25 ESTNewsMirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-07 04:44 ESTNewsMirum Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-06 05:07 ESTNewsMirum Pharmaceuticals GAAP EPS of -$1.17 beats by $0.23, revenue of $12.89M beats by $4.43MN/A
2022-03-10 02:23 ESTNewsMirum Pharmaceuticals reports Q4 resultsN/A
2022-03-10 02:23 ESTNewsMirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-09 09:31 ESTNewsMirum Pharmaceuticals Q4 2021 Earnings PreviewN/A
2022-02-12 01:19 ESTNewsMirum Pharmaceuticals grants stock options under inducement planN/A
2021-12-17 06:35 ESTNewsMirum Pharmaceuticals Gets The 'Thumbs Up'N/A
2021-12-15 14:30 ESTNewsMirum Pharmaceuticals to join NASDAQ Biotechnology IndexN/A
2021-11-17 21:27 ESTNewsMirum Pharmaceuticals to sell Rare Pediatric Disease PRV for $110MN/A
2021-11-16 04:18 ESTNewsMirum Pharmaceuticals reports Q3 resultsN/A
2021-11-16 04:18 ESTNewsMirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-16 04:18 ESTNewsMirum Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-12 04:54 ESTNewsMirum Pharmaceuticals: Livmarli Approval Could Spark A Bull Run For This Young BiotechN/A
2021-10-27 22:00 ESTNewsWarning: MIRM is at high risk of performing badlyN/A
2021-09-29 19:13 ESTNewsFDA approves Mirum Pharmaceuticals' Alagille syndrome treatment LivmarliN/A
2021-09-22 00:37 ESTNewsMirum Pharmaceuticals (MIRM) Investor Presentation - SlideshowN/A
2021-09-22 00:24 ESTNewsMirum submits application to EMA for maralixibat in Alagille SyndromeN/A
2021-09-22 00:12 ESTNewsMirum and Takeda ink exclusive licensing agreement to commercialize maralixibat in JapanN/A
2021-08-25 00:56 ESTNewsMirum And Maralixibat In Pediatric Cholestasis: The DifferentiationN/A
2021-08-08 15:26 ESTNewsMirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-06 06:42 ESTNewsMirum Pharmaceuticals beats on revenueN/A
2021-07-27 13:01 ESTNewsMirum Pharma inks maralixibat development deal for rare liver disease in South KoreaN/A
2021-07-21 15:36 ESTNewsMirum Is Undervalued Despite Expected Tough CompetitionN/A
2021-07-21 15:35 ESTNewsMirum Pharmaceuticals highlights maralixibat liver disease data analysesN/A
2021-07-21 15:34 ESTNewsMirum adds veteran biotechnology executive Carol Brosgart to board of directorsN/A
2021-07-21 15:27 ESTNewsAnalysis shows safety of Mirum's maralixibat for liver disorder maintained over five yearsN/A

About Mirum Pharmaceuticals, Inc (MIRM):

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company's lead product candidate is Maralixibat, an investigational oral drug that is in Phase 3 clinical trial for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It is also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. The company was incorporated in 2018 and is headquartered in Foster City, California.

MIRM Quotes by TradingView

See Advanced Chart

General

  • Name Mirum Pharmaceuticals, Inc
  • Symbol MIRM
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 68
  • Fiscal Year EndDecember
  • IPO Date2019-07-18
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Web URLhttp://www.mirumpharma.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 4.53
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$3.56
  • Next Year EPS Estimate -$2.39
  • Next Quarter EPS Estimate -$0.64
  • Return on Assets -34%
  • Return on Equity -68%
  • Earnings Per Share -$28.94
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 610.52 million
  • PE Ratio -18.84
  • Analyst Target Price $50.29
  • Book Value Per Share $6.48
View More

Share Statistics

  • Shares Outstanding 30.42 million
  • Shares Float 12.19 million
  • % Held by Insiders 909%
  • % Held by Institutions 70.89%
  • Shares Short 674051
  • Shares Short Prior Month 637658
  • Short Ratio 5.61
  • Short % of Float 4%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • 52 Week High $27.43
  • 52 Week Low $10.14
  • 50 Day Moving Average 19.23
  • 200 Day Moving Average 19.6
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Mirum Pharmaceuticals, Inc (MIRM) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Mirum Pharmaceuticals, Inc (MIRM) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-09$N/A-$1.43-$0.98-45.49%
2020-09-302020-11-12$N/A-$0.86-$0.9812.46%
2020-06-302020-08-06$N/A-$0.93-$0.87-6.5%
2020-03-312020-05-07$N/A-$0.86-$0.84-2.83%
2019-12-312020-03-12$N/A-$0.79-$0.856.73%
2019-09-302019-11-06$N/A-$0.84-$0.63-34.14%
2019-06-302019-08-28$N/A-$0.59-$0.590.47%

Mirum Pharmaceuticals, Inc (MIRM) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Mirum Pharmaceuticals, Inc (MIRM) Chart:

Mirum Pharmaceuticals, Inc (MIRM) News:

Below you will find a list of latest news for Mirum Pharmaceuticals, Inc (MIRM) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Mirum Pharmaceuticals, Inc (MIRM) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-07-18200CALL0 0378.2TRUE00
2025-07-1822.50CALL0 0337.18TRUE00
2025-07-18250CALL0 0301.04TRUE00
2025-07-18300CALL0 0239.19TRUE00
2025-07-18350CALL0 080.63TRUE00
2025-07-18400CALL0 653.77TRUE00
2025-07-18456.6CALL0 879.1TRUE00
2025-07-18500CALL0 427.49TRUE00
2025-07-18550.7CALL4 6442.98FALSE-0.6-0.46
2025-07-18600CALL0 0110.08FALSE00
2025-07-18650CALL0 0134.55FALSE00
2025-07-18700CALL0 0154.55FALSE00
2025-07-18750CALL0 0172.14FALSE00
2025-07-18200PUT0 0213.93FALSE00
2025-07-1822.50PUT0 0346.02FALSE00
2025-07-18250PUT0 1309.39FALSE00
2025-07-18300PUT0 1246.71FALSE00
2025-07-18350PUT0 0193.58FALSE00
2025-07-18400PUT0 2146.36FALSE00
2025-07-18450PUT0 051.97FALSE00
2025-07-18501.95PUT0 155.42FALSE00
2025-07-18555.03PUT1 043.14TRUE5.030
2025-07-18600PUT0 056.72TRUE00
2025-07-18650PUT0 066.67TRUE00
2025-07-18700PUT0 084.76TRUE00
2025-07-18750PUT0 094.7TRUE00
2025-08-15250CALL0 085.16TRUE00
2025-08-15300CALL0 079.79TRUE00
2025-08-15350CALL0 057.29TRUE00
2025-08-15400CALL0 052.74TRUE00
2025-08-15450CALL0 049.85TRUE00
2025-08-15504CALL0 146.12TRUE00
2025-08-15550CALL0 054.79FALSE00
2025-08-15600CALL0 071.63FALSE00
2025-08-15650CALL0 087.87FALSE00
2025-08-15700CALL0 0101.14FALSE00
2025-08-15750CALL0 0113.66FALSE00
2025-08-15250PUT0 0205.88FALSE00
2025-08-15300PUT0 0164.3FALSE00
2025-08-15350PUT0 0129.06FALSE00
2025-08-15400PUT0 087.99FALSE00
2025-08-15450PUT0 067.66FALSE00
2025-08-15500PUT0 050.92FALSE00
2025-08-15556.23PUT1 048.62TRUE6.230
2025-08-15600PUT0 048.85TRUE00
2025-08-15650PUT0 047.59TRUE00
2025-08-15700PUT0 061.8TRUE00
2025-08-15750PUT0 067.26TRUE00
2025-10-17200CALL0 0165.44TRUE00
2025-10-1722.50CALL0 0149.36TRUE00
2025-10-17250CALL0 0132.89TRUE00
2025-10-17300CALL0 063.61TRUE00
2025-10-17350CALL0 044.24TRUE00
2025-10-17400CALL0 049.07TRUE00
2025-10-17454.5CALL0 1245.73TRUE00
2025-10-17506.54CALL0 145.76TRUE00
2025-10-17550CALL0 1443.4FALSE00
2025-10-17602CALL0 5851.26FALSE00
2025-10-17650CALL0 249.78FALSE00
2025-10-17700CALL0 166.92FALSE00
2025-10-17750CALL0 274.74FALSE00
2025-10-17200PUT0 095.34FALSE00
2025-10-1722.50PUT0 0154.21FALSE00
2025-10-17250PUT0 0138.03FALSE00
2025-10-17300PUT0 1110.36FALSE00
2025-10-17350PUT0 086.93FALSE00
2025-10-17400PUT0 166.14FALSE00
2025-10-17450PUT0 848.08FALSE00
2025-10-17507.6PUT0 648.11FALSE00
2025-10-17550PUT0 046.14TRUE00
2025-10-17600PUT0 048.65TRUE00
2025-10-17650PUT0 046.46TRUE00
2025-10-17700PUT0 047.66TRUE00
2025-10-17750PUT0 052.59TRUE00
2025-12-19150CALL0 0171TRUE00
2025-12-1917.50CALL0 0149.99TRUE00
2025-12-19200CALL0 068.04TRUE00
2025-12-1922.50CALL0 066.64TRUE00
2025-12-19250CALL0 256.2TRUE00
2025-12-19300CALL0 056.39TRUE00
2025-12-19350CALL0 451.04TRUE00
2025-12-194012CALL0 4448.84TRUE00
2025-12-19459.5CALL0 246.87TRUE00
2025-12-19508.6CALL0 5544.16TRUE00
2025-12-19554.45CALL0 445.05FALSE00
2025-12-19603.5CALL0 1645.54FALSE00
2025-12-19652.9CALL0 18748FALSE00
2025-12-19700CALL0 051.58FALSE00
2025-12-19750CALL0 159.22FALSE00
2025-12-19150PUT0 094.57FALSE00
2025-12-1917.50PUT0 0156.27FALSE00
2025-12-19200PUT0 183.26FALSE00
2025-12-1922.50PUT0 3124.41FALSE00
2025-12-19250PUT0 1111.43FALSE00
2025-12-19300PUT0 288.53FALSE00
2025-12-19350PUT0 269.87FALSE00
2025-12-19400PUT0 98954.36FALSE00
2025-12-19450PUT0 950.47FALSE00
2025-12-19505.4PUT0 646.87FALSE00
2025-12-19558.5PUT0 146.73TRUE00
2025-12-19600PUT0 047.83TRUE00
2025-12-19650PUT0 047.98TRUE00
2025-12-19700PUT0 047.74TRUE00
2025-12-19750PUT0 045.27TRUE00
2026-01-1622.50CALL0 066.22TRUE00
2026-01-16250CALL0 043.29TRUE00
2026-01-16300CALL0 047.95TRUE00
2026-01-16350CALL0 053.35TRUE00
2026-01-16400CALL0 049.57TRUE00
2026-01-16450CALL0 046.88TRUE00
2026-01-16507.34CALL0 1246.07TRUE00
2026-01-16556CALL0 144.97FALSE00
2026-01-16600CALL0 045.97FALSE00
2026-01-16650CALL0 147.87FALSE00
2026-01-16700CALL0 050.91FALSE00
2026-01-16750CALL0 054.77FALSE00
2026-01-1622.50PUT0 0116.28FALSE00
2026-01-16250PUT0 0103.79FALSE00
2026-01-16300PUT0 083.18FALSE00
2026-01-16350PUT0 065.75FALSE00
2026-01-16400PUT0 051.5FALSE00
2026-01-16455PUT0 247.99FALSE00
2026-01-16500PUT0 046.69FALSE00
2026-01-16559.2PUT0 245.56TRUE00
2026-01-16600PUT0 044.65TRUE00
2026-01-16650PUT0 046.45TRUE00
2026-01-16700PUT0 047.58TRUE00
2026-01-16750PUT0 048.41TRUE00

Latest MIRM Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST4$20.27
Jun 13, 2022 7:59 PM EST34$20.26
Jun 13, 2022 7:59 PM EST50$20.26
Jun 13, 2022 7:59 PM EST50$20.26
Jun 13, 2022 7:59 PM EST100$20.24

Mirum Pharmaceuticals, Inc (MIRM) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000156459020029555/0001564590-20-029555-index.htm
2019-06-28UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1759425/000000000019010501/0000000000-19-010501-index.htm
2019-07-10UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1759425/000000000019010921/0000000000-19-010921-index.htm
2019-12-30UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1759425/000000000019016859/0000000000-19-016859-index.htm
2020-08-07UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1759425/000000000020007237/0000000000-20-007237-index.htm
2019-12-27DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1759425/000095012319012069/0000950123-19-012069-index.htm
2019-07-30SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1759425/000107261319000249/0001072613-19-000249-index.htm
2019-12-16SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759425/000117266119002410/0001172661-19-002410-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759425/000117266120000737/0001172661-20-000737-index.htm
2019-06-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1759425/000119312519184371/0001193125-19-184371-index.htm
2019-07-08S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1759425/000119312519189959/0001193125-19-189959-index.htm
2019-07-08CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1759425/000119312519189965/0001193125-19-189965-index.htm
2019-07-12S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1759425/000119312519193277/0001193125-19-193277-index.htm
2019-07-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1759425/000119312519193289/0001193125-19-193289-index.htm
2019-07-158-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1759425/000119312519194022/0001193125-19-194022-index.htm
2019-07-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1759425/000119312519194112/0001193125-19-194112-index.htm
2019-07-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1759425/000119312519194115/0001193125-19-194115-index.htm
2019-07-18424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1759425/000119312519196500/0001193125-19-196500-index.htm
2019-07-23SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1759425/000119312519200063/0001193125-19-200063-index.htm
2019-07-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000119312519202499/0001193125-19-202499-index.htm
2019-07-26SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1759425/000119312519204056/0001193125-19-204056-index.htm
2019-08-01SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1759425/000119312519210092/0001193125-19-210092-index.htm
2019-08-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000119312519232419/0001193125-19-232419-index.htm
2019-08-28S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1759425/000119312519232544/0001193125-19-232544-index.htm
2019-12-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000119312519324949/0001193125-19-324949-index.htm
2020-01-06S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1759425/000119312520002291/0001193125-20-002291-index.htm
2020-01-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1759425/000119312520002347/0001193125-20-002347-index.htm
2020-01-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1759425/000119312520002352/0001193125-20-002352-index.htm
2020-01-09424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1759425/000119312520004784/0001193125-20-004784-index.htm
2020-01-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000119312520007165/0001193125-20-007165-index.htm
2020-01-17SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1759425/000119312520009903/0001193125-20-009903-index.htm
2020-04-29SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1759425/000119312520126318/0001193125-20-126318-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000119380519000651/0001193805-19-000651-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000119380519000660/0001193805-19-000660-index.htm
2019-07-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759425/000119380519000662/0001193805-19-000662-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759425/000119380520000192/0001193805-20-000192-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042429/0001209191-19-042429-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042433/0001209191-19-042433-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042435/0001209191-19-042435-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042437/0001209191-19-042437-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042439/0001209191-19-042439-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042441/0001209191-19-042441-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042442/0001209191-19-042442-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042445/0001209191-19-042445-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042446/0001209191-19-042446-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042447/0001209191-19-042447-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042448/0001209191-19-042448-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042449/0001209191-19-042449-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042451/0001209191-19-042451-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042453/0001209191-19-042453-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042454/0001209191-19-042454-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042455/0001209191-19-042455-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042456/0001209191-19-042456-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042457/0001209191-19-042457-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042458/0001209191-19-042458-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042460/0001209191-19-042460-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042470/0001209191-19-042470-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042476/0001209191-19-042476-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042479/0001209191-19-042479-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042482/0001209191-19-042482-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042486/0001209191-19-042486-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042489/0001209191-19-042489-index.htm
2019-07-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042657/0001209191-19-042657-index.htm
2019-07-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042970/0001209191-19-042970-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043021/0001209191-19-043021-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043022/0001209191-19-043022-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043023/0001209191-19-043023-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043024/0001209191-19-043024-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043052/0001209191-19-043052-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043053/0001209191-19-043053-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043054/0001209191-19-043054-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043055/0001209191-19-043055-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043056/0001209191-19-043056-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043057/0001209191-19-043057-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043058/0001209191-19-043058-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043059/0001209191-19-043059-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043060/0001209191-19-043060-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043061/0001209191-19-043061-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043062/0001209191-19-043062-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043063/0001209191-19-043063-index.htm
2019-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119049089/0001209191-19-049089-index.htm
2019-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119049090/0001209191-19-049090-index.htm
2019-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119049091/0001209191-19-049091-index.htm
2019-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119049092/0001209191-19-049092-index.htm
2019-09-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119049309/0001209191-19-049309-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119050105/0001209191-19-050105-index.htm
2019-10-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119054233/0001209191-19-054233-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119054240/0001209191-19-054240-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120000307/0001209191-20-000307-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120003335/0001209191-20-003335-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120003338/0001209191-20-003338-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120003342/0001209191-20-003342-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120003345/0001209191-20-003345-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120003348/0001209191-20-003348-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120020665/0001209191-20-020665-index.htm
2020-04-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120026416/0001209191-20-026416-index.htm
2020-04-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120026418/0001209191-20-026418-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120036572/0001209191-20-036572-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120036581/0001209191-20-036581-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120036587/0001209191-20-036587-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120036594/0001209191-20-036594-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120036597/0001209191-20-036597-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120036618/0001209191-20-036618-index.htm
2020-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120056690/0001209191-20-056690-index.htm
2019-07-16CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1759425/000135445719000353/0001354457-19-000353-index.htm
2019-09-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759425/000139506419000029/0001395064-19-000029-index.htm
2019-08-2810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1759425/000156459019033345/0001564590-19-033345-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000156459019040998/0001564590-19-040998-index.htm
2019-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1759425/000156459019041030/0001564590-19-041030-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000156459020010454/0001564590-20-010454-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1759425/000156459020010471/0001564590-20-010471-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1759425/000156459020019713/0001564590-20-019713-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1759425/000156459020019725/0001564590-20-019725-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000156459020022831/0001564590-20-022831-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1759425/000156459020022856/0001564590-20-022856-index.htm
2020-05-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1759425/000156459020023010/0001564590-20-023010-index.htm
2020-06-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000156459020029555/0001564590-20-029555-index.htm
2020-08-03S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1759425/000156459020035305/0001564590-20-035305-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000156459020037717/0001564590-20-037717-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1759425/000156459020037771/0001564590-20-037771-index.htm
2020-08-10S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1759425/000156459020038927/0001564590-20-038927-index.htm
2019-07-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1759425/999999999519001627/9999999995-19-001627-index.htm
2020-01-08EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1759425/999999999520000041/9999999995-20-000041-index.htm
2020-08-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1759425/999999999520002122/9999999995-20-002122-index.htm
2019-07-10SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1759425/999999999719006082/9999999997-19-006082-index.htm

Mirum Pharmaceuticals, Inc (MIRM) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Mirum Pharmaceuticals, Inc (MIRM). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 909%
Institutional Ownership: 7089%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-09-10Laura BregeDirectorBuy10,000.0011.22112,200.0010,000.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049309/0001209191-19-049309-index.htm
2019-09-06Pamela VigChief Scientific OfficerBuy1,600.0010.9617,539.201,600.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049091/0001209191-19-049091-index.htm
2019-09-06Pamela VigChief Scientific OfficerBuy12.0011.88142.561,612.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049091/0001209191-19-049091-index.htm
2019-07-22James E Flynn10% Share HolderBuy166,000.0015.002,490,000.00166,000.00https://www.sec.gov/Archives/edgar/data/1759425/000119380519000660/0001193805-19-000660-index.htm
2019-09-06Laurent FischerDirectorBuy1,720.0010.7118,429.281,720.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049089/0001209191-19-049089-index.htm
2019-07-22James E Flynn10% Share HolderBuy166,000.0015.002,490,000.001,724,456.00https://www.sec.gov/Archives/edgar/data/1759425/000119380519000660/0001193805-19-000660-index.htm
2019-09-06Ian ClementsSVP Finance & CommunicationsBuy1,801.0011.0719,937.071,801.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049092/0001209191-19-049092-index.htm
2019-07-22Niall O'DonnellDirectorBuy300,000.0015.004,500,000.001,921,118.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043023/0001209191-19-043023-index.htm
2019-09-06Christopher PeetzPresident and CEOBuy4,750.0010.9151,805.88192,250.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049090/0001209191-19-049090-index.htm
2019-09-09Christopher PeetzPresident and CEOBuy2,000.0010.9021,800.00194,250.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049090/0001209191-19-049090-index.htm
2019-09-09Christopher PeetzPresident and CEOBuy2,320.0011.3526,332.00196,570.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049090/0001209191-19-049090-index.htm
2019-07-22Holdings A/S Novo10% Share HolderBuy575,000.0015.008,625,000.002,445,147.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119042970/0001209191-19-042970-index.htm
2020-10-30Edwin Jonathan TuckerChief Medical OfficerBuy25,000.007.70192,500.0031,000.00https://www.sec.gov/Archives/edgar/data/1759425/000120919120056690/0001209191-20-056690-index.htm
2019-09-09Laurent FischerDirectorBuy1,670.0010.5417,601.803,390.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049089/0001209191-19-049089-index.htm
2020-03-19Edwin Jonathan TuckerChief Medical OfficerBuy2,000.009.9119,818.003,500.00https://www.sec.gov/Archives/edgar/data/1759425/000120919120020665/0001209191-20-020665-index.htm
2019-07-22Frazier Life Sciences IX, L.P.10% Share HolderBuy450,000.0015.006,750,000.003,566,912.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043024/0001209191-19-043024-index.htm
2019-07-22Patrick J HeronDirectorBuy450,000.0015.006,750,000.003,566,912.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043022/0001209191-19-043022-index.htm
2019-09-09Laurent FischerDirectorBuy300.0011.303,390.003,690.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049089/0001209191-19-049089-index.htm
2019-09-06Ian ClementsSVP Finance & CommunicationsBuy2,199.0011.8726,102.134,000.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049092/0001209191-19-049092-index.htm
2019-07-22Ali Behbahani10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043055/0001209191-19-043055-index.htm
2019-07-22Anthony A. Jr. Florence10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043057/0001209191-19-043057-index.htm
2019-07-22Carmen Chang10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043056/0001209191-19-043056-index.htm
2019-07-22DAVID M MOTT10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043060/0001209191-19-043060-index.htm
2019-07-22FOREST BASKETT10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043054/0001209191-19-043054-index.htm
2019-07-22JOSHUA MAKOWER10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043059/0001209191-19-043059-index.htm
2019-07-22Mohamad Makhzoumi10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043058/0001209191-19-043058-index.htm
2019-07-22New Enterprise Associates 16, L.P.10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043052/0001209191-19-043052-index.htm
2019-07-22Paul Edward Walker10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043063/0001209191-19-043063-index.htm
2019-07-22PETER J BARRIS10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043053/0001209191-19-043053-index.htm
2019-07-22Peter W. Sonsini10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043062/0001209191-19-043062-index.htm
2019-07-22SCOTT D SANDELL10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043061/0001209191-19-043061-index.htm
2019-09-10Laurent FischerDirectorBuy960.0010.299,881.474,650.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049089/0001209191-19-049089-index.htm
2019-09-16Laurent FischerDirectorBuy452.009.474,280.445,102.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119050105/0001209191-19-050105-index.htm
2020-03-20Edwin Jonathan TuckerChief Medical OfficerBuy2,500.0011.9029,740.006,000.00https://www.sec.gov/Archives/edgar/data/1759425/000120919120020665/0001209191-20-020665-index.htm
2019-09-17Laurent FischerDirectorBuy1,648.009.3715,435.176,750.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119050105/0001209191-19-050105-index.htm